Showing results (151-160 of 425) with videos related to
Sort By:
Pageof 43
Gut|December 10, 2024
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse eventsEleonora De Martin, Claudia A M Fulgenzi, Ciro Celsa, et al.Journal of Palliative Medicine|October 5, 2016
Intensity of Integrated Primary and Specialist Home-Based Palliative Care for Chronic Diseases in Northeast Italy and Its Impact on End-of-Life Hospital AccessEliana Ferroni, Francesco Avossa, Franco Figoli, et al.Chemotherapy|January 9, 2022
New Frontiers in the Medical Therapy of Hepatocellular CarcinomaClaudia Angela Maria Fulgenzi, Antonio D'Alessio, Thomas Talbot, et al.British Journal of Anaesthesia|September 25, 2013
Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patientsV Libri, J S R Gibbs, D J Pinato, et al.Alimentary Pharmacology & Therapeutics|October 21, 2014
Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective studyD J Pinato, G Karamanakos, T Arizumi, et al.European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparisonIon Agirrezabal, Mohamed Bouattour, David J Pinato, et al.Expert Review of Molecular Diagnostics|March 3, 2022
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinomaAmbreen Muhammed, Antonio D'Alessio, Andrei Enica, et al.Journal of Translational Medicine|December 12, 2022
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunityZhen Zhang, David Rafei-Shamsabadi, Saskia Lehr, et al.British Journal of Cancer|November 16, 2013
An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomesD J Pinato, T M Tan, S T K Toussi, et al.Frontiers in Endocrinology|April 29, 2024
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survivalLisa Yang, Sruthi Murthy, Alessio Cortellini, et al.Pageof 43